nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—Methylprednisolone—psoriatic arthritis	0.149	0.167	CbGbCtD
Tolvaptan—ABCB1—Betamethasone—psoriatic arthritis	0.097	0.108	CbGbCtD
Tolvaptan—ABCB1—Prednisolone—psoriatic arthritis	0.0957	0.107	CbGbCtD
Tolvaptan—ABCB1—Prednisone—psoriatic arthritis	0.0904	0.101	CbGbCtD
Tolvaptan—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0894	0.0999	CbGbCtD
Tolvaptan—CYP3A4—Triamcinolone—psoriatic arthritis	0.0677	0.0757	CbGbCtD
Tolvaptan—CYP3A4—Betamethasone—psoriatic arthritis	0.0581	0.065	CbGbCtD
Tolvaptan—CYP3A4—Prednisolone—psoriatic arthritis	0.0573	0.0641	CbGbCtD
Tolvaptan—ABCB1—Dexamethasone—psoriatic arthritis	0.0564	0.0631	CbGbCtD
Tolvaptan—CYP3A4—Prednisone—psoriatic arthritis	0.0542	0.0605	CbGbCtD
Tolvaptan—ABCB1—Methotrexate—psoriatic arthritis	0.0453	0.0507	CbGbCtD
Tolvaptan—CYP3A4—Dexamethasone—psoriatic arthritis	0.0338	0.0378	CbGbCtD
Tolvaptan—Gastrointestinal haemorrhage—Auranofin—psoriatic arthritis	0.00329	0.0313	CcSEcCtD
Tolvaptan—Hypernatraemia—Prednisolone—psoriatic arthritis	0.00275	0.0261	CcSEcCtD
Tolvaptan—Hypernatraemia—Triamcinolone—psoriatic arthritis	0.00253	0.024	CcSEcCtD
Tolvaptan—Hypernatraemia—Methylprednisolone—psoriatic arthritis	0.00252	0.024	CcSEcCtD
Tolvaptan—Hypernatraemia—Dexamethasone—psoriatic arthritis	0.00229	0.0218	CcSEcCtD
Tolvaptan—Hypernatraemia—Betamethasone—psoriatic arthritis	0.00229	0.0218	CcSEcCtD
Tolvaptan—Hypernatraemia—Prednisone—psoriatic arthritis	0.002	0.019	CcSEcCtD
Tolvaptan—Dysgeusia—Auranofin—psoriatic arthritis	0.00194	0.0184	CcSEcCtD
Tolvaptan—Anorexia—Auranofin—psoriatic arthritis	0.00154	0.0146	CcSEcCtD
Tolvaptan—Deep vein thrombosis—Methotrexate—psoriatic arthritis	0.00144	0.0137	CcSEcCtD
Tolvaptan—Decreased appetite—Auranofin—psoriatic arthritis	0.00141	0.0134	CcSEcCtD
Tolvaptan—Constipation—Auranofin—psoriatic arthritis	0.00138	0.0131	CcSEcCtD
Tolvaptan—Ecchymosis—Prednisolone—psoriatic arthritis	0.00131	0.0124	CcSEcCtD
Tolvaptan—Ecchymosis—Triamcinolone—psoriatic arthritis	0.0012	0.0114	CcSEcCtD
Tolvaptan—Ecchymosis—Methylprednisolone—psoriatic arthritis	0.0012	0.0114	CcSEcCtD
Tolvaptan—Pruritus—Auranofin—psoriatic arthritis	0.00114	0.0109	CcSEcCtD
Tolvaptan—Diarrhoea—Auranofin—psoriatic arthritis	0.00111	0.0105	CcSEcCtD
Tolvaptan—Ecchymosis—Dexamethasone—psoriatic arthritis	0.00109	0.0104	CcSEcCtD
Tolvaptan—Ecchymosis—Betamethasone—psoriatic arthritis	0.00109	0.0104	CcSEcCtD
Tolvaptan—Nausea—Auranofin—psoriatic arthritis	0.000961	0.00912	CcSEcCtD
Tolvaptan—Ecchymosis—Prednisone—psoriatic arthritis	0.00095	0.00902	CcSEcCtD
Tolvaptan—Hyperuricaemia—Methotrexate—psoriatic arthritis	0.000946	0.00899	CcSEcCtD
Tolvaptan—Respiratory failure—Methotrexate—psoriatic arthritis	0.000894	0.00849	CcSEcCtD
Tolvaptan—Blood uric acid increased—Methotrexate—psoriatic arthritis	0.000894	0.00849	CcSEcCtD
Tolvaptan—Pulmonary embolism—Methotrexate—psoriatic arthritis	0.000878	0.00834	CcSEcCtD
Tolvaptan—Breast disorder—Methylprednisolone—psoriatic arthritis	0.00087	0.00826	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.000849	0.00806	CcSEcCtD
Tolvaptan—Ecchymosis—Methotrexate—psoriatic arthritis	0.000794	0.00754	CcSEcCtD
Tolvaptan—Urine output increased—Methotrexate—psoriatic arthritis	0.000794	0.00754	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Prednisone—psoriatic arthritis	0.000763	0.00724	CcSEcCtD
Tolvaptan—Polyuria—Methotrexate—psoriatic arthritis	0.000726	0.00689	CcSEcCtD
Tolvaptan—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.000683	0.00648	CcSEcCtD
Tolvaptan—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.000683	0.00648	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.000673	0.00639	CcSEcCtD
Tolvaptan—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000655	0.00622	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.00065	0.00618	CcSEcCtD
Tolvaptan—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000618	0.00587	CcSEcCtD
Tolvaptan—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000604	0.00574	CcSEcCtD
Tolvaptan—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000602	0.00571	CcSEcCtD
Tolvaptan—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.0006	0.0057	CcSEcCtD
Tolvaptan—Hyperglycaemia—Prednisone—psoriatic arthritis	0.000595	0.00565	CcSEcCtD
Tolvaptan—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000586	0.00557	CcSEcCtD
Tolvaptan—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00058	0.00551	CcSEcCtD
Tolvaptan—Breast disorder—Methotrexate—psoriatic arthritis	0.000576	0.00547	CcSEcCtD
Tolvaptan—Malaise—Prednisolone—psoriatic arthritis	0.00057	0.00541	CcSEcCtD
Tolvaptan—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000569	0.0054	CcSEcCtD
Tolvaptan—Syncope—Prednisolone—psoriatic arthritis	0.000567	0.00538	CcSEcCtD
Tolvaptan—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000555	0.00527	CcSEcCtD
Tolvaptan—Angiopathy—Dexamethasone—psoriatic arthritis	0.00055	0.00522	CcSEcCtD
Tolvaptan—Angiopathy—Betamethasone—psoriatic arthritis	0.00055	0.00522	CcSEcCtD
Tolvaptan—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000539	0.00512	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000538	0.00511	CcSEcCtD
Tolvaptan—Discomfort—Prednisolone—psoriatic arthritis	0.000532	0.00505	CcSEcCtD
Tolvaptan—Malaise—Triamcinolone—psoriatic arthritis	0.000524	0.00498	CcSEcCtD
Tolvaptan—Malaise—Methylprednisolone—psoriatic arthritis	0.000523	0.00497	CcSEcCtD
Tolvaptan—Syncope—Triamcinolone—psoriatic arthritis	0.000521	0.00495	CcSEcCtD
Tolvaptan—Syncope—Methylprednisolone—psoriatic arthritis	0.00052	0.00494	CcSEcCtD
Tolvaptan—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000518	0.00492	CcSEcCtD
Tolvaptan—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000516	0.0049	CcSEcCtD
Tolvaptan—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000511	0.00485	CcSEcCtD
Tolvaptan—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00051	0.00484	CcSEcCtD
Tolvaptan—Shock—Prednisolone—psoriatic arthritis	0.000507	0.00482	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00049	0.00466	CcSEcCtD
Tolvaptan—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000489	0.00465	CcSEcCtD
Tolvaptan—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000489	0.00465	CcSEcCtD
Tolvaptan—Discomfort—Triamcinolone—psoriatic arthritis	0.000489	0.00464	CcSEcCtD
Tolvaptan—Discomfort—Methylprednisolone—psoriatic arthritis	0.000488	0.00463	CcSEcCtD
Tolvaptan—Dry mouth—Triamcinolone—psoriatic arthritis	0.000484	0.00459	CcSEcCtD
Tolvaptan—Renal failure—Methotrexate—psoriatic arthritis	0.000483	0.00458	CcSEcCtD
Tolvaptan—Angiopathy—Prednisone—psoriatic arthritis	0.000479	0.00454	CcSEcCtD
Tolvaptan—Immune system disorder—Prednisone—psoriatic arthritis	0.000477	0.00452	CcSEcCtD
Tolvaptan—Malaise—Betamethasone—psoriatic arthritis	0.000476	0.00452	CcSEcCtD
Tolvaptan—Malaise—Dexamethasone—psoriatic arthritis	0.000476	0.00452	CcSEcCtD
Tolvaptan—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000474	0.0045	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000473	0.00449	CcSEcCtD
Tolvaptan—Syncope—Dexamethasone—psoriatic arthritis	0.000473	0.00449	CcSEcCtD
Tolvaptan—Syncope—Betamethasone—psoriatic arthritis	0.000473	0.00449	CcSEcCtD
Tolvaptan—Shock—Triamcinolone—psoriatic arthritis	0.000467	0.00443	CcSEcCtD
Tolvaptan—Shock—Methylprednisolone—psoriatic arthritis	0.000466	0.00442	CcSEcCtD
Tolvaptan—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000464	0.00441	CcSEcCtD
Tolvaptan—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000464	0.0044	CcSEcCtD
Tolvaptan—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000464	0.0044	CcSEcCtD
Tolvaptan—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00046	0.00436	CcSEcCtD
Tolvaptan—Malnutrition—Prednisone—psoriatic arthritis	0.000459	0.00436	CcSEcCtD
Tolvaptan—Discomfort—Betamethasone—psoriatic arthritis	0.000444	0.00421	CcSEcCtD
Tolvaptan—Discomfort—Dexamethasone—psoriatic arthritis	0.000444	0.00421	CcSEcCtD
Tolvaptan—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000435	0.00413	CcSEcCtD
Tolvaptan—Urethral disorder—Methotrexate—psoriatic arthritis	0.000432	0.0041	CcSEcCtD
Tolvaptan—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00043	0.00409	CcSEcCtD
Tolvaptan—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00043	0.00409	CcSEcCtD
Tolvaptan—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000426	0.00405	CcSEcCtD
Tolvaptan—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000425	0.00404	CcSEcCtD
Tolvaptan—Shock—Dexamethasone—psoriatic arthritis	0.000423	0.00402	CcSEcCtD
Tolvaptan—Shock—Betamethasone—psoriatic arthritis	0.000423	0.00402	CcSEcCtD
Tolvaptan—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000422	0.00401	CcSEcCtD
Tolvaptan—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000422	0.00401	CcSEcCtD
Tolvaptan—Malaise—Prednisone—psoriatic arthritis	0.000414	0.00393	CcSEcCtD
Tolvaptan—Syncope—Prednisone—psoriatic arthritis	0.000412	0.00391	CcSEcCtD
Tolvaptan—Anorexia—Betamethasone—psoriatic arthritis	0.00041	0.0039	CcSEcCtD
Tolvaptan—Anorexia—Dexamethasone—psoriatic arthritis	0.00041	0.0039	CcSEcCtD
Tolvaptan—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000409	0.00389	CcSEcCtD
Tolvaptan—Loss of consciousness—Prednisone—psoriatic arthritis	0.000404	0.00383	CcSEcCtD
Tolvaptan—Angiopathy—Methotrexate—psoriatic arthritis	0.0004	0.0038	CcSEcCtD
Tolvaptan—Immune system disorder—Methotrexate—psoriatic arthritis	0.000398	0.00378	CcSEcCtD
Tolvaptan—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000397	0.00377	CcSEcCtD
Tolvaptan—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000391	0.00371	CcSEcCtD
Tolvaptan—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00039	0.0037	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000388	0.00369	CcSEcCtD
Tolvaptan—Discomfort—Prednisone—psoriatic arthritis	0.000386	0.00367	CcSEcCtD
Tolvaptan—Malnutrition—Methotrexate—psoriatic arthritis	0.000384	0.00364	CcSEcCtD
Tolvaptan—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00038	0.00361	CcSEcCtD
Tolvaptan—Dysgeusia—Methotrexate—psoriatic arthritis	0.000376	0.00357	CcSEcCtD
Tolvaptan—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000375	0.00356	CcSEcCtD
Tolvaptan—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000375	0.00356	CcSEcCtD
Tolvaptan—Decreased appetite—Betamethasone—psoriatic arthritis	0.000374	0.00355	CcSEcCtD
Tolvaptan—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000374	0.00355	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000372	0.00353	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000372	0.00353	CcSEcCtD
Tolvaptan—Shock—Prednisone—psoriatic arthritis	0.000369	0.0035	CcSEcCtD
Tolvaptan—Nervous system disorder—Prednisone—psoriatic arthritis	0.000368	0.00349	CcSEcCtD
Tolvaptan—Skin disorder—Prednisone—psoriatic arthritis	0.000364	0.00346	CcSEcCtD
Tolvaptan—Anorexia—Prednisone—psoriatic arthritis	0.000357	0.00339	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000356	0.00338	CcSEcCtD
Tolvaptan—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000355	0.00337	CcSEcCtD
Tolvaptan—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000355	0.00337	CcSEcCtD
Tolvaptan—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000349	0.00332	CcSEcCtD
Tolvaptan—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000349	0.00331	CcSEcCtD
Tolvaptan—Malaise—Methotrexate—psoriatic arthritis	0.000346	0.00329	CcSEcCtD
Tolvaptan—Dizziness—Prednisolone—psoriatic arthritis	0.000341	0.00324	CcSEcCtD
Tolvaptan—Asthenia—Triamcinolone—psoriatic arthritis	0.00034	0.00323	CcSEcCtD
Tolvaptan—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00034	0.00323	CcSEcCtD
Tolvaptan—Body temperature increased—Betamethasone—psoriatic arthritis	0.00034	0.00323	CcSEcCtD
Tolvaptan—Asthenia—Methylprednisolone—psoriatic arthritis	0.00034	0.00322	CcSEcCtD
Tolvaptan—Pruritus—Triamcinolone—psoriatic arthritis	0.000336	0.00319	CcSEcCtD
Tolvaptan—Pruritus—Methylprednisolone—psoriatic arthritis	0.000335	0.00318	CcSEcCtD
Tolvaptan—Decreased appetite—Prednisone—psoriatic arthritis	0.000326	0.00309	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000325	0.00308	CcSEcCtD
Tolvaptan—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000324	0.00307	CcSEcCtD
Tolvaptan—Headache—Prednisolone—psoriatic arthritis	0.000323	0.00307	CcSEcCtD
Tolvaptan—Discomfort—Methotrexate—psoriatic arthritis	0.000323	0.00307	CcSEcCtD
Tolvaptan—Constipation—Prednisone—psoriatic arthritis	0.000321	0.00304	CcSEcCtD
Tolvaptan—Dizziness—Triamcinolone—psoriatic arthritis	0.000314	0.00298	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000313	0.00297	CcSEcCtD
Tolvaptan—Dizziness—Methylprednisolone—psoriatic arthritis	0.000313	0.00297	CcSEcCtD
Tolvaptan—Feeling abnormal—Prednisone—psoriatic arthritis	0.000309	0.00293	CcSEcCtD
Tolvaptan—Asthenia—Betamethasone—psoriatic arthritis	0.000309	0.00293	CcSEcCtD
Tolvaptan—Asthenia—Dexamethasone—psoriatic arthritis	0.000309	0.00293	CcSEcCtD
Tolvaptan—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000307	0.00292	CcSEcCtD
Tolvaptan—Nausea—Prednisolone—psoriatic arthritis	0.000306	0.00291	CcSEcCtD
Tolvaptan—Pruritus—Dexamethasone—psoriatic arthritis	0.000305	0.00289	CcSEcCtD
Tolvaptan—Pruritus—Betamethasone—psoriatic arthritis	0.000305	0.00289	CcSEcCtD
Tolvaptan—Skin disorder—Methotrexate—psoriatic arthritis	0.000304	0.00289	CcSEcCtD
Tolvaptan—Anorexia—Methotrexate—psoriatic arthritis	0.000299	0.00284	CcSEcCtD
Tolvaptan—Headache—Triamcinolone—psoriatic arthritis	0.000297	0.00282	CcSEcCtD
Tolvaptan—Headache—Methylprednisolone—psoriatic arthritis	0.000296	0.00282	CcSEcCtD
Tolvaptan—Body temperature increased—Prednisone—psoriatic arthritis	0.000296	0.00281	CcSEcCtD
Tolvaptan—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000294	0.0028	CcSEcCtD
Tolvaptan—Diarrhoea—Betamethasone—psoriatic arthritis	0.000294	0.0028	CcSEcCtD
Tolvaptan—Dizziness—Dexamethasone—psoriatic arthritis	0.000285	0.0027	CcSEcCtD
Tolvaptan—Dizziness—Betamethasone—psoriatic arthritis	0.000285	0.0027	CcSEcCtD
Tolvaptan—Nausea—Triamcinolone—psoriatic arthritis	0.000282	0.00268	CcSEcCtD
Tolvaptan—Nausea—Methylprednisolone—psoriatic arthritis	0.000281	0.00267	CcSEcCtD
Tolvaptan—Hypersensitivity—Prednisone—psoriatic arthritis	0.000276	0.00262	CcSEcCtD
Tolvaptan—Decreased appetite—Methotrexate—psoriatic arthritis	0.000272	0.00259	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00027	0.00257	CcSEcCtD
Tolvaptan—Headache—Betamethasone—psoriatic arthritis	0.00027	0.00256	CcSEcCtD
Tolvaptan—Headache—Dexamethasone—psoriatic arthritis	0.00027	0.00256	CcSEcCtD
Tolvaptan—Asthenia—Prednisone—psoriatic arthritis	0.000269	0.00255	CcSEcCtD
Tolvaptan—Pruritus—Prednisone—psoriatic arthritis	0.000265	0.00252	CcSEcCtD
Tolvaptan—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000258	0.00245	CcSEcCtD
Tolvaptan—Diarrhoea—Prednisone—psoriatic arthritis	0.000256	0.00243	CcSEcCtD
Tolvaptan—Nausea—Betamethasone—psoriatic arthritis	0.000256	0.00243	CcSEcCtD
Tolvaptan—Nausea—Dexamethasone—psoriatic arthritis	0.000256	0.00243	CcSEcCtD
Tolvaptan—Dizziness—Prednisone—psoriatic arthritis	0.000248	0.00235	CcSEcCtD
Tolvaptan—Body temperature increased—Methotrexate—psoriatic arthritis	0.000248	0.00235	CcSEcCtD
Tolvaptan—Headache—Prednisone—psoriatic arthritis	0.000235	0.00223	CcSEcCtD
Tolvaptan—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000231	0.00219	CcSEcCtD
Tolvaptan—Asthenia—Methotrexate—psoriatic arthritis	0.000225	0.00213	CcSEcCtD
Tolvaptan—Nausea—Prednisone—psoriatic arthritis	0.000223	0.00211	CcSEcCtD
Tolvaptan—Pruritus—Methotrexate—psoriatic arthritis	0.000222	0.0021	CcSEcCtD
Tolvaptan—Diarrhoea—Methotrexate—psoriatic arthritis	0.000214	0.00203	CcSEcCtD
Tolvaptan—Dizziness—Methotrexate—psoriatic arthritis	0.000207	0.00197	CcSEcCtD
Tolvaptan—Headache—Methotrexate—psoriatic arthritis	0.000196	0.00186	CcSEcCtD
Tolvaptan—Nausea—Methotrexate—psoriatic arthritis	0.000186	0.00177	CcSEcCtD
